HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

KN 93

reduces dopamine content in PC12h cells
Also Known As:
2-(N-(2-hydroxyethyl)-N-(4-methoxybenzenesulfonyl))amino-N-(4-chlorocinnamyl)-N-methylbenzylamine; KN-93; Benzenesulfonamide, N-(2-(((3-(4-chlorophenyl)-2-propenyl)methylamino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxy-
Networked: 61 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yang, Huang-Tian: 3 articles (08/2009 - 12/2004)
2. Kranias, Evangelia G: 2 articles (07/2015 - 03/2007)
3. Zayzafoon, Majd: 2 articles (01/2015 - 09/2007)
4. Crispín, José C: 2 articles (11/2014 - 02/2011)
5. Tsokos, George C: 2 articles (11/2014 - 02/2011)
6. Adameova, Adriana: 2 articles (03/2014 - 08/2012)
7. Carnicka, Slavka: 2 articles (03/2014 - 08/2012)
8. Ravingerova, Tana: 2 articles (03/2014 - 08/2012)
9. Rajtik, Tomas: 2 articles (03/2014 - 08/2012)
10. Szobi, Adrian: 2 articles (03/2014 - 08/2012)

Related Diseases

1. Dyskinesias (Dyskinesia)
2. Endometrial Neoplasms (Endometrial Cancer)
3. Parkinson Disease (Parkinson's Disease)
4. Anoxia (Hypoxia)
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. Levodopa (L Dopa)
2. Calcium-Calmodulin-Dependent Protein Kinase Type 2
3. Phosphotransferases (Kinase)
4. N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)
5. Thymidine
6. Staphylococcal Protein A (A, Protein)
7. bisindolylmaleimide
8. KT 5823
9. KN 62
10. protein kinase modulator

Related Therapies and Procedures

1. Injections
2. Spinal Injections